<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36206625</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling.</ArticleTitle><Pagination><StartPage>104296</StartPage><MedlinePgn>104296</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104296</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2022.104296</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(22)00478-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of disease. 9-20% of hospitalized patients with severe lung disease die from COVID-19 and a substantial number of survivors develop long-COVID. Our objective was to provide comprehensive insights into the pathophysiology of severe COVID-19 and to identify liquid biomarkers for disease severity and therapy response.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied a total of 85 lungs (n = 31 COVID autopsy samples; n = 7 influenza A autopsy samples; n = 18 interstitial lung disease explants; n = 24 healthy controls) using the highest resolution Synchrotron radiation-based hierarchical phase-contrast tomography, scanning electron microscopy of microvascular corrosion casts, immunohistochemistry, matrix-assisted laser desorption ionization mass spectrometry imaging, and analysis of mRNA expression and biological pathways. Plasma samples from all disease groups were used for liquid biomarker determination using ELISA. The anatomic/molecular data were analyzed as a function of patients' hospitalization time.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The observed patchy/mosaic appearance of COVID-19 in conventional lung imaging resulted from microvascular occlusion and secondary lobular ischemia. The length of hospitalization was associated with increased intussusceptive angiogenesis. This was associated with enhanced angiogenic, and fibrotic gene expression demonstrated by molecular profiling and metabolomic analysis. Increased plasma fibrosis markers correlated with their pulmonary tissue transcript levels and predicted disease severity. Plasma analysis confirmed distinct fibrosis biomarkers (TSP2, GDF15, IGFBP7, Pro-C3) that predicted the fatal trajectory in COVID-19.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Pulmonary severe COVID-19 is a consequence of secondary lobular microischemia and fibrotic remodelling, resulting in a distinctive form of fibrotic interstitial lung disease that contributes to long-COVID.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This project was made possible by a number of funders. The full list can be found within the Declaration of interests / Acknowledgements section at the end of the manuscript.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ackermann</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Pathology and Molecular Pathology, Helios University Clinic Wuppertal, University of Witten/Herdecke, Germany; Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg-University Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamp</LastName><ForeName>Jan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werlein</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Claire L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Centre for Advanced Biomedical Imaging, University College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Helge</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prade</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Unit Analytical Pathology, Helmholtz Zentrum M&#xfc;nchen - German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surabattula</LastName><ForeName>Rambabu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Willi L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany; Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Disney</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodey</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Diamond Light Source, Oxfordshire, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illig</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Hannover Unified Biobank, Hannover Medical School, Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeming</LastName><ForeName>Diana J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Hannover Unified Biobank, Hannover Medical School, Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karsdal</LastName><ForeName>Morten A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Nordic Bioscience Biomarkers and Research, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzankov</LastName><ForeName>Alexandar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boor</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;hnel</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xe4;nger</LastName><ForeName>Florian P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verleden</LastName><ForeName>Stijn E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University Hospital Antwerp Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kvasnicka</LastName><ForeName>Hans M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Institute of Pathology and Molecular Pathology, Helios University Clinic Wuppertal, University of Witten/Herdecke, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreipe</LastName><ForeName>Hans H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haverich</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Cellular Biology and Pharmacology, Center for Translational Research, Florida International University, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walch</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nordic Bioscience Biomarkers and Research, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tafforeau</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>European Synchrotron Radiation Facility, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Peter D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Hannover Unified Biobank, Hannover Medical School, Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoeper</LastName><ForeName>Marius M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany. Electronic address: hoeper.marius@mh-hannover.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welte</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeliger</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>David</LastName><ForeName>Sascha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuppan</LastName><ForeName>Detlef</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentzer</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Laboratory of Adaptive and Regenerative Biology, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonigk</LastName><ForeName>Danny D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 HL146369</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/R025673/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 HL060190</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/S007687/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P01 HL134610</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>EBioMedicine. 2022 Dec;86:104328. doi: 10.1016/j.ebiom.2022.104328</RefSource><PMID Version="1">36335670</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="Y">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Fibrogenesis</Keyword><Keyword MajorTopicYN="N">Intussusceptive angiogenesis</Keyword></KeywordList><CoiStatement>Declaration of interests HHK received fees for lectures and consultations from Roche Pharma AG, Novartis, AstraZeneca, Genomic Health, Pfizer, and Amgen, all outside the present study. MMH received fees for lectures and consultations from Acceleron, Actelion, Bayer, GSK, Janssen, MSD, and Pfizer, all outside the present study. TW declares funding by the German Ministry of Research and Education. MAK and DJL declare the possession of &#x201c;Nordic Bioscience&#x201d; stock options. BS received fees for lectures from Boehringer Ingelheim. The other authors have no potential conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>7</Day><Hour>18</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36206625</ArticleId><ArticleId IdType="pmc">PMC9535314</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2022.104296</ArticleId><ArticleId IdType="pii">S2352-3964(22)00478-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>W&#xf6;lfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465&#x2013;469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1. Erratum in: Nature. 2020 Dec;588(7839):E35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265&#x2013;269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3. Erratum in: Nature. 2020 Apr;580(7803):E7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ZJ, Subramaniam A, Ponnapa Reddy M, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54&#x2013;66. doi: 10.1164/rccm.202006-2405OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2405OC</ArticleId><ArticleId IdType="pmc">PMC7781141</ArticleId><ArticleId IdType="pubmed">33119402</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069&#x2013;1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00363-4</ArticleId><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, Valabhji J. Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care. Curr Obes Rep. 2021;10(3):282&#x2013;289. doi: 10.1007/s13679-021-00448-8. Epub 2021 Aug 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00448-8</ArticleId><ArticleId IdType="pmc">PMC8353061</ArticleId><ArticleId IdType="pubmed">34374955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120&#x2013;128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganin D, Mayo SC, Gureyev TE, Miller PR, Wilkins SW. Simultaneous phase and amplitude extraction from a single defocused image of a homogeneous object. J Microsc. 2002;206(Pt 1):33&#x2013;40. doi: 10.1046/j.1365-2818.2002.01010.x. PMID: 12000561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2818.2002.01010.x</ArticleId><ArticleId IdType="pubmed">12000561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirone A, Brun E, Gouillart E, Tafforeau P, Kieffer J. The PyHST2 hybrid distributed code for high speed tomographic reconstruction with iterative reconstruction and a priori knowledge capabilities. Nucl Instrum Methods Phys Res Sect B: Beam Interact Mater Atoms. 2014;324:41&#x2013;48.</Citation></Reference><Reference><Citation>Lyckegaard A, Johnson G, Tafforeau P. Correction of ring artifacts in X-ray tomographic images. Int J Tomogr Stat. 2011;18:1&#x2013;9.</Citation></Reference><Reference><Citation>Webb WR. Thin-section CT of the secondary pulmonary lobule: anatomy and the image&#x2013;the 2004 Fleischner lecture. Radiology. 2006;239(2):322&#x2013;338. doi: 10.1148/radiol.2392041968. Epub 2006 Mar 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2392041968</ArticleId><ArticleId IdType="pubmed">16543587</ArticleId></ArticleIdList></Reference><Reference><Citation>van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104&#x2013;e107. doi: 10.1158/0008-5472.CAN-17-0339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0339</ArticleId><ArticleId IdType="pmc">PMC5672828</ArticleId><ArticleId IdType="pubmed">29092951</ArticleId></ArticleIdList></Reference><Reference><Citation>Verleden SE, Vasilescu DM, Willems S, et al. The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med. 2014;189(3):292&#x2013;300. doi: 10.1164/rccm.201310-1894OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201310-1894OC</ArticleId><ArticleId IdType="pubmed">24354907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Konerding MA. Vascular casting for the study of vascular morphogenesis. Methods Mol Biol. 2015;1214:49&#x2013;66. doi: 10.1007/978-1-4939-1462-3_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-1462-3_5</ArticleId><ArticleId IdType="pubmed">25468599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentzer SJ, Konerding MA. Intussusceptive angiogenesis: expansion and remodeling of microvascular networks. Angiogenesis. 2014;17(3):499&#x2013;509. doi: 10.1007/s10456-014-9428-3. Epub 2014 Mar 26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-014-9428-3</ArticleId><ArticleId IdType="pmc">PMC4063884</ArticleId><ArticleId IdType="pubmed">24668225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Stark H, Neubert L, et al. Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases. Eur Respir J. 2020;55(3) doi: 10.1183/13993003.00933-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00933-2019</ArticleId><ArticleId IdType="pubmed">31806721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Kim YO, Wagner WL, et al. Effects of nintedanib on the microvascular architecture in a lung fibrosis model. Angiogenesis. 2017;20(3):359&#x2013;372. doi: 10.1007/s10456-017-9543-z. Epub 2017 Mar 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-017-9543-z</ArticleId><ArticleId IdType="pmc">PMC7412751</ArticleId><ArticleId IdType="pubmed">28283856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):1&#x2013;12. doi: 10.1186/gb-2002-3-7-research0034. RESEARCH0034Epub 2002 Jun 18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2002-3-7-research0034</ArticleId><ArticleId IdType="pmc">PMC126239</ArticleId><ArticleId IdType="pubmed">12184808</ArticleId></ArticleIdList></Reference><Reference><Citation>Internet:https://www.qiagen.com/us/products/discovery-and-translational-research/next-generation-sequencing/informatics-and-data/interpretation-content-databases/ingenuity-pathway-analysis/ Last Accessed 27 April 2022.</Citation></Reference><Reference><Citation>Nielsen MJ, Nedergaard AF, Sun S, et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am J Transl Res. 2013;5(3):303&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3633973</ArticleId><ArticleId IdType="pubmed">23634241</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeming DJ, Nielsen MJ, Dai Y, et al. Enzyme-linked immunosorbent serum assay specific for the 7S domain of collagen type IV (P4NP 7S): a marker related to the extracellular matrix remodeling during liver fibrogenesis. Hepatol Res. 2012;42(5):482&#x2013;493. doi: 10.1111/j.1872-034X.2011.00946.x. Epub 2012 Jan 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1872-034X.2011.00946.x</ArticleId><ArticleId IdType="pubmed">22221767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliadis E, Veidal SS, Hansen C, Karsdal MA, Leeming DJ. Circulating levels of a collagen type v propeptide fragment in a carbon tetrachloride reversible model of liver fibrosis. Biomark Insights. 2012;7:159&#x2013;166. doi: 10.4137/BMI.S10975. Epub 2012 Dec 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/BMI.S10975</ArticleId><ArticleId IdType="pmc">PMC3572874</ArticleId><ArticleId IdType="pubmed">23440040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Henriksen K, Karsdal MA, et al. Collagen type III and VI turnover in response to long-term immobilization. PLoS One. 2015;10(12) doi: 10.1371/journal.pone.0144525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144525</ArticleId><ArticleId IdType="pmc">PMC4671681</ArticleId><ArticleId IdType="pubmed">26641456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly A, Buck A, Balluff B, et al. High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue. Nat Protoc. 2016;11(8):1428&#x2013;1443. doi: 10.1038/nprot.2016.081. Epub 2016 Jul 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2016.081</ArticleId><ArticleId IdType="pubmed">27414759</ArticleId></ArticleIdList></Reference><Reference><Citation>Aichler M, Borgmann D, Krumsiek J, et al. N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking &#x3b2; cell dysfunction in type 2 diabetes. Cell Metab. 2017;25(6):1334&#x2013;1347.e4. doi: 10.1016/j.cmet.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.04.012</ArticleId><ArticleId IdType="pubmed">28591636</ArticleId></ArticleIdList></Reference><Reference><Citation>Aichler M, Kunzke T, Buck A, et al. Molecular similarities and differences from human pulmonary fibrosis and corresponding mouse model: MALDI imaging mass spectrometry in comparative medicine. Lab Invest. 2018;98(1):141&#x2013;149. doi: 10.1038/labinvest.2017.110. Epub 2017 Oct 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2017.110</ArticleId><ArticleId IdType="pubmed">29035378</ArticleId></ArticleIdList></Reference><Reference><Citation>Prade VM, Kunzke T, Feuchtinger A, et al. De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry. Mol Metab. 2020;36 doi: 10.1016/j.molmet.2020.01.017. Epub 2020 Feb 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2020.01.017</ArticleId><ArticleId IdType="pmc">PMC7149754</ArticleId><ArticleId IdType="pubmed">32278304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang M, Som A, Carey D, et al. Pulmonary vascular manifestations of COVID-19 pneumonia. Radiol Cardiothorac Imaging. 2020;2(3) doi: 10.1148/ryct.2020200277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200277</ArticleId><ArticleId IdType="pmc">PMC7307217</ArticleId><ArticleId IdType="pubmed">34036264</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, Doyle DJ, Mangal R. Mosaic perfusion pattern" on dual-energy CT in COVID-19 pneumonia: pulmonary vasoplegia or vasoconstriction? Radiol Cardiothorac Imaging. 2020;2(5) doi: 10.1148/ryct.2020200433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200433</ArticleId><ArticleId IdType="pmc">PMC7485086</ArticleId><ArticleId IdType="pubmed">33778633</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh CL, Tafforeau P, Wagner WL, et al. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat Methods. 2021;18(12):1532&#x2013;1541. doi: 10.1038/s41592-021-01317-x. Epub 2021 Nov 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01317-x</ArticleId><ArticleId IdType="pmc">PMC8648561</ArticleId><ArticleId IdType="pubmed">34737453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Tafforeau P, Wagner WL, et al. The bronchial circulation in COVID-19 pneumonia. Am J Respir Crit Care Med. 2022;205(1):121&#x2013;125. doi: 10.1164/rccm.202103-0594IM.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202103-0594IM</ArticleId><ArticleId IdType="pmc">PMC8865596</ArticleId><ArticleId IdType="pubmed">34734553</ArticleId></ArticleIdList></Reference><Reference><Citation>Doglioni C, Ravaglia C, Chilosi M, et al. Covid-19 interstitial pneumonia: histological and immunohistochemical features on cryobiopsies. Respiration. 2021;100(6):488&#x2013;498. doi: 10.1159/000514822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514822</ArticleId><ArticleId IdType="pmc">PMC8018216</ArticleId><ArticleId IdType="pubmed">33725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith ML. The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go. Mod Pathol. 2022;35(suppl 1):8&#x2013;14. doi: 10.1038/s41379-021-00889-5. Epub 2021 Aug 31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00889-5</ArticleId><ArticleId IdType="pmc">PMC8695374</ArticleId><ArticleId IdType="pubmed">34465882</ArticleId></ArticleIdList></Reference><Reference><Citation>Braubach P, Werlein C, Verleden SE, et al. Pulmonary fibroelastotic remodelling revisited. Cells. 2021;10(6):1362. doi: 10.3390/cells10061362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061362</ArticleId><ArticleId IdType="pmc">PMC8227669</ArticleId><ArticleId IdType="pubmed">34205982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonigk D, Werlein C, Acker T, et al. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Virchows Arch. 2022;481(2):139&#x2013;159. doi: 10.1007/s00428-022-03319-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-022-03319-2</ArticleId><ArticleId IdType="pmc">PMC8975445</ArticleId><ArticleId IdType="pubmed">35364700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergin C, Roggli V, Coblentz C, Chiles C. The secondary pulmonary lobule: normal and abnormal CT appearances. AJR Am J Roentgenol. 1988;151(1):21&#x2013;25. doi: 10.2214/ajr.151.1.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.151.1.21</ArticleId><ArticleId IdType="pubmed">3259815</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolcock AJ, Macklem PT. Mechanical factors influencing collateral ventilation in human, dog, and pig lungs. J Appl Physiol. 1971;30(1):99&#x2013;115. doi: 10.1152/jappl.1971.30.1.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1971.30.1.99</ArticleId><ArticleId IdType="pubmed">5538799</ArticleId></ArticleIdList></Reference><Reference><Citation>Baile EM. The anatomy and physiology of the bronchial circulation. J Aerosol Med. 1996;9(1):1&#x2013;6. doi: 10.1089/jam.1996.9.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jam.1996.9.1</ArticleId><ArticleId IdType="pubmed">10160199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Mentzer SJ, Kolb M, Jonigk D. Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. Eur Respir J. 2020;56(5) doi: 10.1183/13993003.03147-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03147-2020</ArticleId><ArticleId IdType="pmc">PMC7530910</ArticleId><ArticleId IdType="pubmed">33008942</ArticleId></ArticleIdList></Reference><Reference><Citation>Croake A, Croake MF. In: Essential Radiology Review. Eltorai A, Hyman C, Healey T, editors. Springer; Cham: 2019. Classifying parenchymal lung disease. Book chapter.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-26044-6_14</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccuri F, Bugatti A, Zani A, et al. SARS-CoV-2 Infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells. Microorganisms. 2021;9(7):1438. doi: 10.3390/microorganisms9071438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071438</ArticleId><ArticleId IdType="pmc">PMC8305478</ArticleId><ArticleId IdType="pubmed">34361874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamp JC, Neubert L, Ackermann M, et al. Time-dependent molecular motifs of pulmonary fibrogenesis in COVID-19. Int J Mol Sci. 2022;23(3):1583. doi: 10.3390/ijms23031583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031583</ArticleId><ArticleId IdType="pmc">PMC8835897</ArticleId><ArticleId IdType="pubmed">35163504</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsdal MA, Kraus VB, Shevell D, et al. Profiling and targeting connective tissue remodeling in autoimmunity - a novel paradigm for diagnosing and treating chronic diseases. Autoimmun Rev. 2021;20(1) doi: 10.1016/j.autrev.2020.102706. Epub 2020 Nov 12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102706</ArticleId><ArticleId IdType="pubmed">33188918</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeming DJ, Genovese F, Sand JMB, et al. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir Res. 2021;22(1):38. doi: 10.1186/s12931-020-01590-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01590-y</ArticleId><ArticleId IdType="pmc">PMC7863042</ArticleId><ArticleId IdType="pubmed">33546680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanumegowda C, Farkas L, Kolb M. Angiogenesis in pulmonary fibrosis: too or not enough? Chest. 2012;142(1):200&#x2013;207. doi: 10.1378/chest.11-1962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-1962</ArticleId><ArticleId IdType="pubmed">22796840</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Bridgewood C, Meaney JFM. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19. Lancet Respir Med. 2021;9(6):665&#x2013;672. doi: 10.1016/S2213-2600(21)00213-7. Epub 2021 May 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00213-7</ArticleId><ArticleId IdType="pmc">PMC8121498</ArticleId><ArticleId IdType="pubmed">34000237</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine. 2021;42 doi: 10.1016/j.eclinm.2021.101209. Epub 2021 Nov 23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101209</ArticleId><ArticleId IdType="pmc">PMC8609167</ArticleId><ArticleId IdType="pubmed">34841234</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadista J, Kraven LM, Karjalainen J, et al. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity. EBioMedicine. 2021;65 doi: 10.1016/j.ebiom.2021.103277. Epub 2021 Mar 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103277</ArticleId><ArticleId IdType="pmc">PMC7946355</ArticleId><ArticleId IdType="pubmed">33714028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>